Please login to the form below

Not currently logged in
Email:
Password:

Embrace

This page shows the latest Embrace news and features for those working in and with pharma, biotech and healthcare.

The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel

The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel

Now for the plot twist. The pandemic rescued pharma from the inertia holding back transformation of its go-to-market (GTM) model – forcing companies to release the handbrake and embrace ‘new’ ... Embrace the latest thing, but don’t be seduced by

Latest news

More from news
Approximately 1 fully matching, plus 253 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 115 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 80 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need...
JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...